This is the first study to examine the long-term effect of 5-aminolevulinic acid mainly on serum lipoproteins in dogs with hyperlipidemia. We studied 5 Miniature Schnauzer cases whose fasting serum total triglyceride and very-low-density lipoprotein of triglyceride levels were extremely high (635 ± 116 and 520 ± 92 mg/dL, respectively). Although the total cholesterol values were normal, the very-low-density lipoprotein of cholesterol level was high (49 ± 7 mg/dL). Each dog received a 5-aminolevulinic acid supplement (5 mg/day) orally for 6 months. The mean values of total triglyceride, very-low-density lipoprotein of both triglyceride and cholesterol decreased significantly after the treatment period (319 ± 29, 245 ± 18, and 27 ± 2 mg/dL, respectively, P <0.05). Our present results may present evidence that 5-ALA administration contributes to improvement of hyperlipidemia in Miniature Schnauzer.
CITATION STYLE
Sakai, A., Iwatani, N., & Harada, K. (2020). Improvement effect of 5-aminolevulinic acid on hyperlipidemia in miniature schnauzer dogs: An open study in 5 cases of one pedigree. Yonago Acta Medica, 63(3), 234–238. https://doi.org/10.33160/yam.2020.08.006
Mendeley helps you to discover research relevant for your work.